KRYS
|Krystal Biotech Inc
NASDAQ
USD 126.88
+0.92|+0.73%
Current Price
USD 126.88
Change
+USD 0.92 (0.73%)
P/E Ratio
30.32
Dividend Yield
Market Cap
3.65B
Volume
3,707
Open
USD 125.87
Previous Close
USD 125.96
52-Week High
USD 219.34
52-Week Low
USD 122.80
About Krystal Biotech Inc
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treati...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Krish S. Krishnan M.B.A., M.S.
Employees:275
Headquarters:Pittsburgh, USA
Website:www.krystalbio.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions